These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7985189)

  • 1. [Esophageal lesions induced by iron tablets].
    Hertzenberg SW
    Tidsskr Nor Laegeforen; 1994 Sep; 114(22):2651. PubMed ID: 7985189
    [No Abstract]   [Full Text] [Related]  

  • 2. [Esophageal lesions induced by iron tablets].
    Serck-Hanssen A; Stray N
    Tidsskr Nor Laegeforen; 1994 Aug; 114(18):2129-31. PubMed ID: 7992273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron tablets cause histopathologically distinctive lesions in mucosal biopsies of the stomach and esophagus.
    Eckstein RP; Symons P
    Pathology; 1996 May; 28(2):142-5. PubMed ID: 8743820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristic changes in peptic stomach ulcers after taking iron tablets].
    Grouls V; Seidl C; Marko C
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1232. PubMed ID: 9378049
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron-induced oesophageal injury and pigmentation.
    Nandini CL; Lindop GB; Gillen D; Hendry A; Oien KA
    Histopathology; 2001 Dec; 39(6):643-5. PubMed ID: 11903587
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epibulbar siderosis caused by iron tablets].
    Salminen L; Paasio P; Ekfors T
    Duodecim; 1981; 97(5):262-5. PubMed ID: 7238382
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lesions in the upper esophagus caused by orally administered drugs].
    Hey H; Jørgensen F; Hasselbalch H; Wamberg T; Matzen P
    Ugeskr Laeger; 1983 Aug; 145(32):2450-2. PubMed ID: 6623698
    [No Abstract]   [Full Text] [Related]  

  • 8. Ecabet sodium prevents esophageal lesions induced by the reflux of gastric juice in rats.
    Okuyama K; Saito N; Kume E; Noto T; Nagasaki M
    Inflammopharmacology; 2007 Apr; 15(2):90-4. PubMed ID: 17450449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro study of oesophageal adhesiveness of different commercial formulations containing alendronate.
    Shakweh M; Bravo-Osuna I; Ponchel G
    Eur J Pharm Sci; 2007 Aug; 31(5):262-70. PubMed ID: 17576054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron-induced mucosal pathology of the upper gastrointestinal tract: a common finding in patients on oral iron therapy.
    Kaye P; Abdulla K; Wood J; James P; Foley S; Ragunath K; Atherton J
    Histopathology; 2008 Sep; 53(3):311-7. PubMed ID: 18631194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal stricture associated with alendronate therapy.
    Levine J; Nelson D
    Am J Med; 1997 May; 102(5):489-91. PubMed ID: 9217649
    [No Abstract]   [Full Text] [Related]  

  • 12. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
    Sharma P; Sampliner RE; Camargo E
    Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Poisoning by iron tablets].
    Myhre E
    Lakartidningen; 1965 Dec; 62():Suppl 2:68-9. PubMed ID: 5868143
    [No Abstract]   [Full Text] [Related]  

  • 14. Scope of drug-induced, infectious and allergic esophageal injury.
    Geagea A; Cellier C
    Curr Opin Gastroenterol; 2008 Jul; 24(4):496-501. PubMed ID: 18622166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal injury by apple cider vinegar tablets and subsequent evaluation of products.
    Hill LL; Woodruff LH; Foote JC; Barreto-Alcoba M
    J Am Diet Assoc; 2005 Jul; 105(7):1141-4. PubMed ID: 15983536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcer on Bauhin's valve induced by oral iron therapy.
    Stolte M; Hülskath H
    Endoscopy; 1999 Mar; 31(3):S15-6. PubMed ID: 10344443
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
    Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
    Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective influence of melatonin against acute esophageal lesions involves prostaglandins, nitric oxide and sensory nerves.
    Konturek SJ; Zayachkivska O; Havryluk XO; Brzozowski T; Sliwowski Z; Pawlik M; Konturek PC; Cześnikiewicz-Guzik M; Gzhegotsky MR; Pawlik WW
    J Physiol Pharmacol; 2007 Jun; 58(2):361-77. PubMed ID: 17622703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk in esophageal obstruction with slow-release medications.
    Simko V; Joseph D; Michael S
    J Assoc Acad Minor Phys; 1997; 8(2):38-42. PubMed ID: 9167415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of phase III clinical trial of zeng sheng-ping in the treatment of patients with esophageal epithelial hyperplasia].
    Wang J;
    Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):510-2. PubMed ID: 11235577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.